Skip to main content
. 2022 Jun 21;23(1):59–79. doi: 10.1007/s10742-022-00282-y

Table 2.

Crude and adjusted treatment effects of CABG and PCI at the end of 1, 3, 5, 10 years

Year Endpoint Crude Matching weight adjusted L-table adjusted
OR (95% CI) p value E value OR (95% CI) p value E value OR (95% CI)
1 years MACCE 0.861 (0.789, 0.94) 0.001 1.367 0.713 (0.643, 0.789) < 0.001 1.651 0.424 (0.396, 0.517)
Death 0.998 (0.902, 1.103) 0.965 1.033 0.766 (0.68, 0.862) < 0.001 1.546
Stroke 1.263 (0.882, 1.817) 0.203 1.497 1.186 (0.78, 1.802) 0.424 1.4
MI 0.494 (0.409, 0.591) < 0.001 2.198 0.498 (0.404, 0.614) < 0.001 2.186
Repeat revascularization 0.494 (0.45, 0.543) < 0.001 2.198 0.457 (0.379, 0.55) < 0.001 2.321
3 years MACCE 0.849 (0.792, 0.91) < 0.001 1.39 0.701 (0.646, 0.761) < 0.001 1.676 0.436 (0.369, 0.527)
Death 0.912 (0.844, 0.986) 0.02 1.269 0.719 (0.656, 0.788) < 0.001 1.639
Stroke 1.277 (1.018, 1.605) 0.035 1.513 1.167 (0.897, 1.519) 0.249 1.375
MI 0.57 (0.492, 0.657) < 0.001 1.98 0.558 (0.473, 0.659) < 0.001 2.012
Repeat revascularization 0.466 (0.408, 0.53) < 0.001 2.29 0.486 (0.42, 0.562) < 0.001 2.224
5 years MACCE 0.913 (0.86, 0.97) 0.003 1.267 0.759 (0.707, 0.814) < 0.001 1.56 0.511 (0.451, 0.538)
Death 0.973 (0.912, 1.039) 0.418 1.132 0.785 (0.727, 0.847) < 0.001 1.51 0.457 (0.376, 0.468)
Stroke 1.159 (0.979, 1.372) 0.087 1.364 1.023 (0.842, 1.243) 0.818 1.119 0.694 (0.551, 0.873)
MI 0.583 (0.512, 0.662) < 0.001 1.947 0.57 (0.492, 0.661) < 0.001 1.98 0.358 (0.264, 0.368)
Repeat revascularization 0.48 (0.427, 0.537) < 0.001 2.243 0.497 (0.437, 0.565) < 0.001 2.189 0.304 (0.235, 0.344)
10 years MACCE 1.052 (0.997, 1.111) 0.064 1.188 0.893 (0.839, 0.95) < 0.001 1.306
Death 1.1 (1.041, 1.163) 0.001 1.275 0.917 (0.86, 0.977) 0.008 1.259 0.505 (0.446, 0.582)
Stroke 1.235 (1.086, 1.406) 0.001 1.463 1.111 (0.958, 1.289) 0.165 1.293
MI 0.667 (0.599, 0.741) < 0.001 1.749 0.667 (0.59, 0.753) < 0.001 1.749
Repeat revascularization 0.503 (0.455, 0.554) < 0.001 2.17 0.518 (0.464, 0.579) < 0.001 2.125

MI myocardial infarction, MACCE major adverse cardiac and cerebrovascular events